Search

everythinglearnresearchcommunity

for

Search:↓

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Amitraz effectively treated sarcoptic mange in three alpacas.

Ruxolitinib can help regrow hair in severe alopecia areata.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Letrozole with lifestyle changes improves fertility in women with PCOS.

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ozonated oil and Centella asiatica extract improve wound healing in mice, with each having specific benefits.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

miR-325-3p can slow down brain tumor growth by targeting FOXM1.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Topical tofacitinib is effective and safe for treating alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.